Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06377878 · ClinicalTrials.gov registry record
The Preeclampsia Registry
A clinical trial of Preeclampsia and Hypertensive Disorder of Pregnancy, sponsored by Preeclampsia Foundation.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 1
- Study location
NCT06377878: Recruiting study of Preeclampsia and Hypertensive Disorder of Pregnancy, sponsored by Preeclampsia Foundation.
NCT06377878 is a study of Preeclampsia and Hypertensive Disorder of Pregnancy that is actively recruiting participants, run by Preeclampsia Foundation. The registered enrollment target is 20,000 participants, above the 710-participant average among 48 other Preeclampsia trials with a reported enrollment target (2717% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06377878, a study of Preeclampsia and Hypertensive Disorder of Pregnancy, is actively recruiting participants, sponsored by Preeclampsia Foundation.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of The Preeclampsia Registry is to collect and store medical and other information from women who have been medically diagnosed with preeclampsia or a related hypertensive (high blood pressure) disorder of pregnancy such as eclampsia or HELLP syndrome, their family members, and women who have not had preeclampsia to serve as controls. Information from participants will be used for medical research to try to understand why preeclampsia occurs, how to predict it better, and to develop experimental clinical trials of new treatments. The Registry will consist of a web-based survey and mechanism for collecting and reviewing medical records. This data will be utilized for immediate investigator-driven cross-sectional research projects (after proposal review by the Registry's scientific advisory board and as directed by the PI). Participants may also choose to be contacted regarding possible participation in future studies, about providing a biospecimen, as well as investigator-driven clinical trials. The Registry is anticipated to exist long-term and to serve as a foundation of participants from which to draw for studies of preeclampsia, anticipated to evolve as our scientific understanding of preeclampsia evolves.
Conditions Studied
Study Locations (1)
Florida
- Preeclampsia Foundation - Melbourne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2013-09-01 |
| Est. Completion | 2040-05 |
What NCT06377878 shows while recruiting
NCT06377878 is an observational study that tracks outcomes without assigning an intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus, above the 710-participant average among 48 other Preeclampsia trials with a reported enrollment target (2717% higher).
The record links to 5 conditions, with Preeclampsia appearing as the primary indexed condition, and to 0 interventions.
NCT06377878 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06377878 about?
NCT06377878 is a clinical study titled "The Preeclampsia Registry". The purpose of The Preeclampsia Registry is to collect and store medical and other information from women who have been medically diagnosed with preeclampsia or a related hypertensive (high blood pressure) disorder of pregnancy such as eclampsia or HELLP syndrome, their family members, and women who...
What is the current status of trial NCT06377878?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2013-09-01. Estimated completion is 2040-05.
What conditions does trial NCT06377878 study?
This clinical trial studies the following conditions: Preeclampsia, Hypertensive Disorder of Pregnancy, Toxemia, Eclampsia, HELLP Syndrome.
Who is sponsoring clinical trial NCT06377878?
This trial is sponsored by Preeclampsia Foundation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06377878 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06377878's enrollment target sits among peer trials
20,000 1st of 48 higher than 48 of 48 other Preeclampsia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preeclampsia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories
RECRUITING · Phase 2
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Daily Aspirin Treatment After Preeclampsia
RECRUITING · Early Phase 1
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
Exosome Cargo From Preeclampsia Patients
RECRUITING
-
Prenatal Aspirin and Postpartum Vascular Function
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- NCT02735707 · 20,000 participants · Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI